Not a snowflakes chance mate; we've seen what is possible with the recent push higher - but once that ML drops formally, it'll be a completely different ballgame.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%